Entry Detail



General Information

Database ID:exR0080642
RNA Name:RPS14
RNA Type:mRNA
Chromosome:chr5
Starnd:-
Coordinate:
Start Site(bp):150442635End Site(bp):150449739
External Links:ENSG00000164587



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC068580.4
chr11
1734821
1763954
-
ALDOA
chr16
30064164
30070457
+
ACTG1
chr17
81509971
81523847
-
ACTB
chr7
5527148
5563784
-
ADSL
chr22
40346500
40390463
+
AL136295.1
chr14
24189157
24213473
-
ABLIM1
chr10
114431113
114768061
-
AHCYL1
chr1
109984765
110023742
+
ALDH2
chr12
111766887
111817532
+
ADARB1
chr21
45073853
45226560
+
AC004922.1
chr7
99325879
99394653
+
AC009133.6
chr16
29812261
29820092
+
AASS
chr7
122073549
122144255
-
ACSL4
chrX
109624244
109733403
-
AFAP1
chr4
7758714
7939926
-
AL136295.4
chr14
24180395
24190416
-
AHCYL2
chr7
129225023
129430211
+
AL160269.1
chr9
96235331
96352058
-
ADI1
chr2
3497366
3519531
-
ACTR3
chr2
113890063
113962596
+
ADGRE5
chr19
14380501
14408725
+
AL513165.2
chr9
37512547
37592469
-
AKAP1
chr17
57085092
57121346
+
AC026954.2
chr17
7312661
7319174
-
AL162417.1
chr9
133098121
133163914
-
AKAP17A
chrX
1591604
1602520
+
AL133352.1
chr10
100505628
100529881
-
ADPGK
chr15
72751369
72785846
-
AC027796.3
chr17
3585149
3636249
-
AC004832.3
chr22
30409255
30428990
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-6891-3p
chr6
31355228
31355248
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC010642.2
chr19
58309727
58327248
-
AC013268.5
chr2
109937438
109985124
+
AC018521.5
chr17
47891229
47895812
-
AC024940.6
chr12
31280422
31280895
-
AC040162.3
chr16
67882461
67886367
+
AC063949.2
chr12
92421531
92483680
+
AC104109.4
chr5
134205614
134371044
-
AC125257.1
chr17
41848518
41851447
-
AC132217.1
chr11
2129121
2129964
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA